Knight Therapeutics Investor

Knight Therapeutics Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing
Headquarters:
Westmount, Quebec, Canada
Founded Date:
1995-01-01
Employees Number:
101-250
Funding Status:
IPO
Number Of Exits:
4
Total Funding:
$490,012,033
Estimated Revenue:
$1M to $10M
Last Funding Date:
2022-03-22
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership